These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
308 related articles for article (PubMed ID: 34728682)
1. The immune checkpoint VISTA exhibits high expression levels in human gliomas and associates with a poor prognosis. Ghouzlani A; Lakhdar A; Rafii S; Karkouri M; Badou A Sci Rep; 2021 Nov; 11(1):21504. PubMed ID: 34728682 [TBL] [Abstract][Full Text] [Related]
2. The Expression Pattern and Clinical Significance of the Immune Checkpoint Regulator VISTA in Human Breast Cancer. Xie X; Zhang J; Shi Z; Liu W; Hu X; Qie C; Chen W; Wang Y; Wang L; Jiang J; Liu J Front Immunol; 2020; 11():563044. PubMed ID: 33250890 [TBL] [Abstract][Full Text] [Related]
3. The Promising IgSF11 Immune Checkpoint Is Highly Expressed in Advanced Human Gliomas and Associates to Poor Prognosis. Ghouzlani A; Rafii S; Karkouri M; Lakhdar A; Badou A Front Oncol; 2020; 10():608609. PubMed ID: 33604291 [TBL] [Abstract][Full Text] [Related]
4. Viewing the immune checkpoint VISTA: landscape and outcomes across cancers. Nishizaki D; Kurzrock R; Miyashita H; Adashek JJ; Lee S; Nikanjam M; Eskander RN; Patel H; Botta GP; Nesline MK; Pabla S; Conroy JM; DePietro P; Sicklick JK; Kato S ESMO Open; 2024 Apr; 9(4):102942. PubMed ID: 38503143 [TBL] [Abstract][Full Text] [Related]
5. Expression of the inhibitory B7 family molecule VISTA in human colorectal carcinoma tumors. Xie S; Huang J; Qiao Q; Zang W; Hong S; Tan H; Dong C; Yang Z; Ni L Cancer Immunol Immunother; 2018 Nov; 67(11):1685-1694. PubMed ID: 30128738 [TBL] [Abstract][Full Text] [Related]
6. Enhanced B7-H4 expression in gliomas with low PD-L1 expression identifies super-cold tumors. Chen D; Li G; Ji C; Lu Q; Qi Y; Tang C; Xiong J; Hu J; Yasar FBA; Zhang Y; Hoon DSB; Yao Y; Zhou L J Immunother Cancer; 2020 May; 8(1):. PubMed ID: 32457124 [TBL] [Abstract][Full Text] [Related]
7. Expression and clinical significance of VISTA, B7-H3, and PD-L1 in glioma. Wang LC; Wang YL; He B; Zheng YJ; Yu HC; Liu ZY; Fan RR; Zan X; Liang RC; Wu ZP; Tang X; Wang GQ; Xu JG; Zhou LX Clin Immunol; 2022 Dec; 245():109178. PubMed ID: 36368642 [TBL] [Abstract][Full Text] [Related]
8. VISTA expression is associated with a favorable prognosis in patients with high-grade serous ovarian cancer. Zong L; Zhou Y; Zhang M; Chen J; Xiang Y Cancer Immunol Immunother; 2020 Jan; 69(1):33-42. PubMed ID: 31781843 [TBL] [Abstract][Full Text] [Related]
9. Genetic and clinical characterization of B7-H3 (CD276) expression and epigenetic regulation in diffuse brain glioma. Wang Z; Wang Z; Zhang C; Liu X; Li G; Liu S; Sun L; Liang J; Hu H; Liu Y; Zhang W; Jiang T Cancer Sci; 2018 Sep; 109(9):2697-2705. PubMed ID: 30027617 [TBL] [Abstract][Full Text] [Related]
10. MXRA5 Is a Novel Immune-Related Biomarker That Predicts Poor Prognosis in Glioma. Sun JZ; Zhang JH; Li JB; Yuan F; Tong LQ; Wang XY; Chen LL; Fan XG; Zhang YM; Ren X; Zhang C; Yu SP; Yang XJ Dis Markers; 2021; 2021():6680883. PubMed ID: 34211612 [TBL] [Abstract][Full Text] [Related]
11. Expression and prognostic value of the WEE1 kinase in gliomas. Music D; Dahlrot RH; Hermansen SK; Hjelmborg J; de Stricker K; Hansen S; Kristensen BW J Neurooncol; 2016 Apr; 127(2):381-9. PubMed ID: 26738845 [TBL] [Abstract][Full Text] [Related]
12. Novel roles of VAT1 expression in the immunosuppressive action of diffuse gliomas. Yang P; Wang K; Zhang C; Wang Z; Liu Q; Wang J; Jiang T; Shan X Cancer Immunol Immunother; 2021 Sep; 70(9):2589-2600. PubMed ID: 33576871 [TBL] [Abstract][Full Text] [Related]
13. Prognostic prediction and immune checkpoint profiling in glioma patients through neddylation-associated features. Qi J; Li L; Gao B; Dai K; Shen K; Wu X; Li H; Yu Z; Wang Z; Wang Z Gene; 2024 Dec; 930():148835. PubMed ID: 39127414 [TBL] [Abstract][Full Text] [Related]
14. The correlation of bone morphogenetic protein 2 with poor prognosis in glioma patients. Yang X; Li D; Cheng S; Fan K; Sheng L; Zhang J; Feng B; Xu Z Tumour Biol; 2014 Nov; 35(11):11091-5. PubMed ID: 25099618 [TBL] [Abstract][Full Text] [Related]
15. Tissue Proteome Analysis of Different Grades of Human Gliomas Provides Major Cues for Glioma Pathogenesis. Gollapalli K; Ghantasala S; Atak A; Rapole S; Moiyadi A; Epari S; Srivastava S OMICS; 2017 May; 21(5):275-284. PubMed ID: 28481733 [TBL] [Abstract][Full Text] [Related]
16. High VISTA Expression Correlates With a Favorable Prognosis in Patients With Colorectal Cancer. Zong L; Yu S; Mo S; Zhou Y; Xiang Y; Lu Z; Chen J J Immunother; 2021 Jan; 44(1):22-28. PubMed ID: 33086339 [TBL] [Abstract][Full Text] [Related]
17. CD96, a new immune checkpoint, correlates with immune profile and clinical outcome of glioma. Liu F; Huang J; He F; Ma X; Fan F; Meng M; Zhuo Y; Zhang L Sci Rep; 2020 Jul; 10(1):10768. PubMed ID: 32612110 [TBL] [Abstract][Full Text] [Related]
18. Increased expression of phosphatidylethanolamine-binding protein 4 (PEBP4) strongly associates with human gliomas grade. Huang RQ; Shi DL; Huang W; Chen F; Lu YC J Neurooncol; 2016 Apr; 127(2):235-42. PubMed ID: 26725095 [TBL] [Abstract][Full Text] [Related]
19. Immune Checkpoint-Associated Locations of Diffuse Gliomas Comparing Pediatric With Adult Patients Based on Voxel-Wise Analysis. Zhang L; Zhang B; Dou Z; Wu J; Iranmanesh Y; Jiang B; Sun C; Zhang J Front Immunol; 2021; 12():582594. PubMed ID: 33815356 [No Abstract] [Full Text] [Related]
20. Slit2 and Robo1 expression as biomarkers for assessing prognosis in brain glioma patients. Liu L; Li W; Geng S; Fang Y; Sun Z; Hu H; Liang Z; Yan Z Surg Oncol; 2016 Dec; 25(4):405-410. PubMed ID: 27916173 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]